Booster COVID jabs offered to all adults in EnglandThe UK government has said it will step up its COVID-19 booster vaccination dramatically, with everyone in England Share XBooster COVID jabs offered to all adults in Englandhttps://pharmaphorum.com/news/booster-covid-jabs-offered-to-all-adults-in-england/
COVID booster shots increase immunity, trial showsA trial of booster vaccinations to protect against COVID-19 has shown that the jab significantly strengthens the body’s Share XCOVID booster shots increase immunity, trial showshttps://pharmaphorum.com/news/covid-booster-shots-increase-immunity-trial-shows/
Omicron set to dominate in UK within weeks, says expertThe Omicron variant could supersede other strains of COVID-19 within the next few weeks to become dominant in Share XOmicron set to dominate in UK within weeks, says experthttps://pharmaphorum.com/news/omicron-set-to-dominate-in-uk-within-weeks-says-expert/
UK government rubberstamps millions of extra COVID vaccinesThe UK government has placed a 114 million-dose order with Pfizer/BioNTech and Moderna – sufficient to provide two doses Share XUK government rubberstamps millions of extra COVID vaccineshttps://pharmaphorum.com/news/uk-government-rubberstamps-millions-of-extra-covid-vaccines/
UK accelerates COVID booster plans in response to OmicronThe UK looks set to extend its COVID-19 booster vaccination programme to all over-18s, as the number of Share XUK accelerates COVID booster plans in response to Omicronhttps://pharmaphorum.com/news/uk-accelerates-covid-booster-plans-in-response-to-omicron/
Report suggests UK’s national vaccine facility is on the blockThe UK’s Vaccines Manufacturing and Innovation Centre (VMIC) – unveiled with fanfare by the government in 2018 – Share XReport suggests UK’s national vaccine facility is on the blockhttps://pharmaphorum.com/news/report-suggests-uks-national-vaccine-facility-is-on-the-block/
AstraZeneca cuts the ribbon on its $1bn R&D lab in CambridgeAfter years of delays and rising costs, AstraZeneca has formally unveiled its $1 billion R&D facility in Cambridge, Share XAstraZeneca cuts the ribbon on its $1bn R&D lab in Cambridgehttps://pharmaphorum.com/news/astrazeneca-cuts-the-ribbon-on-its-1bn-rd-lab-in-cambridge/
Valneva gets EU deal for COVID jab, and may sue UKShares in France’s Valneva leaped after it got an EU order to supply 60 million doses of its Share XValneva gets EU deal for COVID jab, and may sue UKhttps://pharmaphorum.com/news/valneva-gets-eu-deal-for-covid-jab-and-may-sue-uk/
Industry welcomes boost to health research in UK budgetGroups representing the biopharma industry have welcomed an increase in health-specific R&D to £5 billion in the UK Share XIndustry welcomes boost to health research in UK budgethttps://pharmaphorum.com/news/industry-welcomes-boost-to-health-research-in-uk-budget/
